Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

ClinicalTrials.gov ID: NCT06039189

Public ClinicalTrials.gov record NCT06039189. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 6:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area (BSA) Moderate Plaque Psoriasis With Special Site Involvement

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of guselkumab compared to an inactive drug in participants with low body surface area moderate plaque psoriasis and special site involvement.

Study identification

NCT ID
NCT06039189
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
338 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 24, 2023 (Actual)
Primary completion
Apr 14, 2025 (Actual)
Completion
Apr 14, 2025 (Actual)
Last update posted
May 1, 2026

2023 – 2025

United States locations

U.S. sites
45
U.S. states
15
U.S. cities
37
Facility City State ZIP Site status
Total Dermatology Birmingham Alabama 35203 —
Cahaba Research Inc Birmingham Alabama 35244 —
California Dermatology & Clinical Research Institute Encinitas California 92024 —
First OC Dermatology Fountain Valley California 92708 —
Practice Wang Riverside California 92505 —
Therapeutics Clinical Research San Diego California 92123 —
Rehlen, Bartlow, Goodman and Baron Dermatology Group Santa Ana California 92701 —
Clinical Science Institute Santa Monica California 90404 —
University of Conn Health Center Farmington Connecticut 06030 —
TrueBlue Clinical Research Brandon Florida 33511 —
Florida Academic Dermatology Centers Coral Gables Florida 33134 —
Revival Research Doral Florida 33122 —
Glick Research Institute Margate Florida 33063 —
Miami VA Healthcare System Miami Florida 33124 —
Tory P Sullivan M D PA North Miami Beach Florida 33162 —
Atlanta Biomedical Clinical Research Atlanta Georgia 303331 —
Kindred Hair and Skin Center Columbia Maryland 21045 —
DermAssociates, PC Rockville Maryland 20850 —
Lawrence J Green MD LLC Rockville Maryland 20850 —
Metro Boston Clinical Partners Brighton Massachusetts 02135 —
DermCare, LLC Quincy Massachusetts 02169 —
Henry Ford Medical Center West Bloomfield Michigan 48322 —
Icahn School of Medicine at Mount Sinai New York New York 10003 —
Markowitz Medical OptiSkin New York New York 10128 —
Accellacare Research of Cary Cary North Carolina 27511 —
Darst Dermatology Charlotte North Carolina 28277 —
Piedmont Plastic Surgery and Dermatology Huntersville North Carolina 28078 —
Bexley dermatology research Bexley Ohio 43209 —
Remington Davis Inc Columbus Ohio 43215 —
Apex Dermatology Mayfield Heights Mayfield Heights Ohio 44124 —
Dermatology and Laser Center of Charleston Charleston South Carolina 29414 —
Palmetto Clinical Trial Services, LLC Fountain Inn South Carolina 29644 —
Nashville Skin: Comprehensive Dermatology Center Nashville Tennessee 37212 —
Tennessee Clinical Research Center Nashville Tennessee 37215 —
Arlington Center for Dermatology Arlington Texas 76011 —
Bellair Dermatology Bellaire Texas 77401 —
Modern Research Associates PLLC Dallas Texas 75231 —
Bare Dermatology Dallas Texas 75235 —
Menter Dermatology Research Institute Dallas Texas 75246 —
Center for Clinical Studies Houston Texas 77004 —
Suzanne Bruce and Associates - The Center for Skin Research Houston Texas 77056-4132 —
Texas Dermatology and Laser Specialists San Antonio Texas 78218 —
Progressive Clinical Research San Antonio Texas 78229 —
Acclaim Dermatology Sugar Land Texas 77479 —
Frontier Derm Partners CRO, LLC Mill Creek Washington 98102 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06039189, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06039189 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →